After reporting robust results, Resmed reckons it won't be subject to US tariffs while the growth of anti-obesity drugs will be a tailwind.

Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look for. ResMed beat analysts’ revenue expectations by 1% last quarter ...

SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the ...

A comprehensive guide for business owners. Do your best ideas come to you burning the midnight oil? If you're a night owl, you'll know that feeling of being in a creative flow as the rest of the world ...

ResMed RMD is gearing up to announce its quarterly earnings on Wednesday, 2025-04-23. Here's a quick overview of what investors should know before the release. Analysts are estimating that ResMed ...

ResMed has appointed Salli Schwartz as the new Chief Investor Relations Officer, effective April 21, 2025. Schwartz brings over two decades of experience from roles in finance at health tech and ...

SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the ...

Throughout the last three months, 5 analysts have evaluated ResMed RMD, offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of their recent ...